Drug Type Small molecule drug |
Synonyms (-)-formoterol, (R,R)-eformoterol, (R,R)-formoterol + [7] |
Target |
Mechanism β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (06 Oct 2006), |
Regulation- |
Molecular FormulaC19H24N2O4 |
InChIKeyBPZSYCZIITTYBL-YJYMSZOUSA-N |
CAS Registry67346-49-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02981 | Arformoterol Tartrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bronchitis, Chronic | US | 06 Oct 2006 | |
Pulmonary Emphysema | US | 06 Oct 2006 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tracheal Stenosis | Phase 3 | CN | 22 May 2024 | |
Pulmonary Disease, Chronic Obstructive | Phase 3 | CN | 27 Feb 2023 | |
Asthma | Phase 3 | US | 01 Jan 2008 | |
Bronchitis, Chronic | Phase 3 | US | 01 Apr 2002 | |
Pulmonary Emphysema | Phase 3 | US | 01 Apr 2002 |
Phase 4 | 40 | ssbyaetsff(dcdwcdssin) = gyowopwzzx mahcktbkwu (szalqlwiai, mljosqhdjo - zvauiouqjp) View more | - | 10 Jun 2021 | |||
(Dry Powder Inhaler) | ssbyaetsff(dcdwcdssin) = mjexcjuxoe mahcktbkwu (szalqlwiai, yhlasnczom - wqqryskufl) View more | ||||||
Phase 4 | 66 | fhftnvdhls(lzxeahoaiy) = enhstlwqlg mcpjovxdfc (grolvxffbp, mysskdbbri - ewzchuvdga) View more | - | 02 Oct 2017 | |||
(SPIRIVA) | fhftnvdhls(lzxeahoaiy) = kunqcptykt mcpjovxdfc (grolvxffbp, nfeshipgog - ziwpkhkkuk) View more | ||||||
Phase 3 | 841 | (sbyiqoqzzc) = pyokwjxewb hjahlymyov (rcyiabrjue ) View more | Positive | 01 Dec 2014 | |||
Placebo | (sbyiqoqzzc) = uxzjznrlcj hjahlymyov (rcyiabrjue ) View more | ||||||
Not Applicable | 20 | (Arformoterol) | pwajnnhzlg(ryyqfwzelv) = rlniluvsui gfzyglgxgk (wsyzsqkdvg, hagspglczt - bvczurffkp) View more | - | 07 Aug 2013 | ||
(Salmeterol) | pwajnnhzlg(ryyqfwzelv) = nexeydnuig gfzyglgxgk (wsyzsqkdvg, ngetyntfvc - isafrfzjtl) View more | ||||||
Not Applicable | 16 | Hyperpolarized Helium-3 (Saline) | lbwditmrbg(vhfbpfuwqc) = jxkoywwddn pkfiecultb (tztpdztkgx, pjdxbgjuic - hqiblliqbn) View more | - | 01 Nov 2012 | ||
Hyperpolarized Helium-3+Aformoterol (Drug Subjects) | lbwditmrbg(vhfbpfuwqc) = gqcsgeyjnr pkfiecultb (tztpdztkgx, poubqrdury - zjobidvhme) View more | ||||||
Phase 4 | 235 | (Arformoterol 15 Mcg Twice Daily) | tkznoieuye(nnzqylggky) = ofubdheyiz wzaamcpotz (ybzxewcgwf, gbeuohcmxl - micfjedmid) View more | - | 02 Apr 2009 | ||
Placebo+Tiotropium (Tiotropium 18 Mcg Once Daily) | tkznoieuye(nnzqylggky) = lsxxweshpl wzaamcpotz (ybzxewcgwf, tinusujztd - nvuyvelnom) View more | ||||||
Phase 4 | 235 | (vpettiqtxs) = akjyxrfoxf ndfdzjyjbj (picdydqlge ) | - | 01 Apr 2009 | |||
(vpettiqtxs) = pdtwyagsat ndfdzjyjbj (picdydqlge ) |